Dynamics of apoptotic activity during antiviral treatment of patients with chronic hepatitis C

被引：0
|
作者：
Kronenberge, B. [1 ]
Sarrazin, C. [1 ]
Mihm, U. [1 ]
von Wagner, M. [1 ]
Piiper, A. [1 ]
Zeuzem, S. [1 ]
Herrmann, E. [1 ]
机构：
[1] Univ Klinikum Saarlandes, Klin Innere Med 2, Homburg, Saar, Germany
来源：
JOURNAL OF HEPATOLOGY | 2006年 / 44卷
关键词：
D O I：
10.1016/S0168-8278(06)80293-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
292
引用
收藏
页码：S114 / S114
页数：1
相关论文
共 50 条
  • [41] Antiviral treatment of chronic hepatitis C in clinical routine
    Maieron, Andreas
    Metz-Gercek, Sigrid
    Hackl, Franz
    Ziachehabi, Alexander
    Fuchsteiner, Harri
    Luger, Christoph
    Mittermayer, Helmut
    Schoefl, Rainer
    WIENER KLINISCHE WOCHENSCHRIFT, 2010, 122 (7-8) : 237 - 242
  • [42] Neuropsychiatric toxicity of antiviral treatment in chronic hepatitis C
    Fontana, RJ
    DIGESTIVE DISEASES, 2000, 18 (03) : 107 - 116
  • [43] Antiviral activity of the interferon α family: biological and pharmacological aspects of the treatment of chronic hepatitis C
    Scagnolari, Carolina
    Antonelli, Guido
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (05) : 693 - 711
  • [44] HEPATITIS C CORE ANTIGEN ASSAY FOR THE MONITORING OF TREATMENT WITH DIRECT ANTIVIRAL AGENTS IN PATIENTS WITH CHRONIC HEPATITIS C
    Loggi, E.
    Cursaro, C.
    Scuteri, A.
    Vukotic, R.
    Grandini, E.
    Margotti, M.
    Guarneri, V.
    Stanzani, M.
    Galli, S.
    Furlini, G.
    Galli, C.
    Landini, M. P.
    Andreone, P.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 : E61 - E61
  • [45] HEPATITIS C CORE ANTIGEN ASSAY FOR THE MONITORING OF TREATMENT WITH DIRECT ANTIVIRAL AGENTS IN PATIENTS WITH CHRONIC HEPATITIS C
    Loggi, E.
    Cursaro, C.
    Scuteri, A.
    Vukotic, R.
    Grandini, E.
    Margotti, M.
    Guarneri, V.
    Stanzani, M.
    Galli, S.
    Furlini, G.
    Galli, C.
    Landini, M. P.
    Andreone, P.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S762 - S762
  • [46] Apoptotic markers in assessing patients with chronic hepatitis C
    Kountouras, J
    Zavos, C
    Chatzopoulos, D
    GASTROENTEROLOGY, 2005, 128 (05) : 1531 - 1532
  • [47] A PROGNOSTIC MODEL TO SELECT PATIENTS FOR PROPHYLACTIC SSRI THERAPY DURING ANTIVIRAL TREATMENT FOR CHRONIC HEPATITIS C INFECTION
    Hotho, Daphne
    Bezemer, Geert
    Hansen, Bettina E.
    Van Gool, Arthur R.
    de Knegt, Robert J.
    Veldt, Bart J.
    Janssen, Harry L.
    HEPATOLOGY, 2011, 54 : 850A - 851A
  • [48] Use of antiviral therapy in patients with chronic hepatitis C
    Dragomiretskaya, Natalia
    Izha, Anna
    Kalinichenko, Nikolay
    Szark-Eckardt, Miroslawa
    Klimczyk, Mariusz
    Cieslicka, Miroslawa
    Muszkieta, Radoslaw
    Prusik, Krzysztof
    Napierala, Marek
    Zukowska, Hanna
    Zukow, Walery
    OPEN MEDICINE, 2015, 10 (01): : 209 - 215
  • [49] Antiviral Activity of Narlaprevir Combined with Ritonavir and Pegylated Interferon in Chronic Hepatitis C Patients
    de Bruijne, Joep
    Bergmann, Jilling F.
    Reesink, Henk W.
    Weegink, Christine J.
    Molenkamp, Richard
    Schinkel, Janke
    Tong, Xiao
    Li, Jing
    Treitel, Michelle A.
    Hughes, Eric A.
    van Lier, Jan Jaap
    van Vliet, Andre A.
    Janssen, Harry L. A.
    de Knegt, Robert J.
    HEPATOLOGY, 2010, 52 (05) : 1590 - 1599
  • [50] eGFR IMPROVEMENT IN CHRONIC HEPATITIS B PATIENTS WITH TELBIVUDINE TREATMENT IS INDEPENDENT OF ANTIVIRAL ACTIVITY
    Gane, E. J.
    Liaw, Y. F.
    Wang, Y.
    Lai, C. -L.
    Rasenack, J.
    Zeuzem, S.
    Chan, H. L. Y.
    Ren, H.
    Dong, Y.
    Uddin, A.
    Jung, M. E.
    Bosset, S.
    Trylesinski, A.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S302 - S302
12345